Moroccan pharma tycoon Lamia Tazi faces $3.35 million loss as Sothema shares dip
Lamia Tazi’s stake in Sothema dips below $65 million as shares slide
Lamia Tazi’s stake in Sothema dips below $65 million as shares slide
The recent financial setback experienced by Tazi underscores the broader challenges facing Sothema and highlights the unpredictable nature of the stock market.
Tazi, the CEO and chairperson of Sothema holds a substantial 8.4-percent stake in the leading healthcare company.
Tazi holds a substantial 8.4-percent stake in the leading healthcare company, or 605,030 issued shares.